Enovis (ENOV) EBITDA (2010 - 2026)
Enovis' (ENOV) quarterly EBITDA came in at $6.5 million in Q2 2026, up 113.96% year-on-year from $3.1 million in Q2 2025, and up 101.3% on a QoQ basis from -$502.2 million in Q4 2025.
Enovis (ENOV) EBITDA (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of EBITDA data on file, last reported at $6.5 million in Q2 2026.
- On a quarterly basis, EBITDA rose 113.96% year-over-year to $6.5 million in Q2 2026; TTM through Apr 2026 was -$1.1 billion, a 36.0% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 billion, down 44.93% from the prior year.
- EBITDA for Q2 2026 stood at $6.5 million, up from -$502.2 million in the prior quarter.
- Over the last five years, EBITDA for ENOV reached as high as $6.5 million in Q2 2026 and fell as low as -$664.7 million in Q4 2024.
- Historically, EBITDA has averaged -$119.4 million across 5 years, with a median of -$28.2 million in 2022.
- Across the five-year window, EBITDA jumped 153.65% in 2022 and tumbled 11450.81% in 2024, its largest moves.
- Year by year, EBITDA stood at -$28.2 million in 2022, then jumped by 79.58% to -$5.8 million in 2023, then tumbled by 11450.81% to -$664.7 million in 2024, then increased by 24.46% to -$502.2 million in 2025, then jumped by 101.3% to $6.5 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were $6.5 million in Q2 2026, -$502.2 million in Q4 2025, and -$558.5 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 6.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 6.53 Mn |
| Dec 31, 2025 | -502.18 Mn |
| Oct 3, 2025 | -558.49 Mn |
| Jul 4, 2025 | -16.80 Mn |
| Apr 4, 2025 | -46.77 Mn |
| Dec 31, 2024 | -664.75 Mn |
| Sep 27, 2024 | -31.74 Mn |
| Jun 28, 2024 | -44.22 Mn |
| Mar 29, 2024 | -35.01 Mn |
| Dec 31, 2023 | -5.76 Mn |
| Sep 29, 2023 | -20.49 Mn |
| Jun 30, 2023 | -14.49 Mn |
| Mar 31, 2023 | -24.97 Mn |
| Dec 31, 2022 | -28.19 Mn |
| Sep 30, 2022 | -17.92 Mn |
| Jul 1, 2022 | 5.55 Mn |
| Apr 1, 2022 | -30.63 Mn |
| Dec 31, 2021 | -18.21 Mn |
| Oct 1, 2021 | -16.11 Mn |
| Jul 2, 2021 | -10.35 Mn |